Elevated C-Reactive Protein Associated With Decreased High-Density Lipoprotein Cholesterol in Men With Spinal Cord Injury

Archives of Physical Medicine and Rehabilitation

Volumn 89, Issue 1, 2008, Pages 36-41

  Liang, Huifang ^a   Mojtahedi, Mina C ^b   Chen, David ^c   Braunschweig, Carol L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

C reactive protein; Cholesterol, HDL; Cross sectional studies; Rehabilitation; Risk factors; Spinal cord injuries

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; RISK FACTOR; SMOKING; SPINAL CORD INJURY; WAIST CIRCUMFERENCE;

ADULT; ANTHROPOMETRY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SMOKING; SPINAL CORD INJURIES;

EID: 37349053802     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2007.08.121     Document Type: Article

References (44)

1. Kocina P. Body composition of spinal cord injured adults. Sports Med 23 (1997) 48-60
2. Bauman W.A., and Spungen A.M. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism 43 (1994) 749-756
3. Imai K., Kadowaki T., and Aizawa Y. Standardized indices of mortality among persons with spinal cord injury: accelerated aging process. Ind Health 42 (2004) 213-218
4. Garshick E., Kelley A., Cohen S.A., et al. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord 43 (2005) 408-416
5. Liang H., Chen D., Wang Y., Rimmer J.H., and Braunschweig C.L. Different risk factor patterns for metabolic syndrome in men with spinal cord injury compared with able-bodied men despite similar prevalence rates. Arch Phys Med Rehabil 88 (2007) 1198-1204
6. Koenig W., Sund M., Frohlich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
7. Sakkinen P., Abbott R.D., Curb J.D., Rodriguez B.L., Yano K., and Tracy R.P. C-reactive protein and myocardial infarction. J Clin Epidemiol 55 (2002) 445-451
8. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
9. Folsom A.R., Aleksic N., Catellier D., Juneja H.S., and Wu K.K. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 144 (2002) 233-238
10. Ridker P.M., Glynn R.J., and Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97 (1998) 2007-2011
11. Centers for Disease Control and Prevention; American Heart Association, Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
12. Frost F., Roach M.J., Kushner I., and Schreiber P. Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury. Arch Phys Med Rehabil 86 (2005) 312-317
13. Manns P.J., McCubbin J.A., and Williams D.P. Fitness, inflammation, and the metabolic syndrome in men with paraplegia. Arch Phys Med Rehabil 86 (2005) 1176-1181
14. Lee M.Y., Myers J., Hayes A., et al. C-reactive protein, metabolic syndrome, and insulin resistance in individuals with spinal cord injury. J Spinal Cord Med 28 (2005) 20-25
15. Hansel B., Kontush A., Bonnefont-Rousselot D., Bruckert E., and Chapman M.J. Alterations in lipoprotein defense against oxidative stress in metabolic syndrome. Curr Atheroscler Rep 8 (2006) 501-509
16. Rohrer L., Hersberger M., and von Eckardstein A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 15 (2004) 269-278
17. Kontush A., and Chapman M.J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58 (2006) 342-374
18. Navab M., Anantharamaiah G.M., Reddy S.T., Van Lenten B.J., Ansell B.J., and Fogelman A.M. Mechanisms of disease: proatherogenic HDL-an evolving field. Nat Clin Pract Endocrinol Metab 2 (2006) 504-511
19. Georgiadis A.N., Papavasiliou E.C., Lourida E.S., et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res Ther 8 (2006) R82
20. LaPorte R.E., Brenes G., Dearwater S., et al. HDL cholesterol across a spectrum of physical activity from quadriplegia to marathon running. Lancet 1 (1983) 1212-1213
21. Dearwater S.R., LaPorte R.E., Robertson R.J., Brenes G., Adams L.L., and Becker D. Activity in the spinal cord-injured patient: an epidemiologic analysis of metabolic parameters. Med Sci Sports Exerc 18 (1986) 541-544
22. Bauman W.A., Adkins R.H., Spungen A.M., Kemp B.J., and Waters R.L. The effect of residual neurological deficit on serum lipoproteins in individuals with chronic spinal cord injury. Spinal Cord 36 (1998) 13-17
23. Bauman W.A., Adkins R.H., Spungen A.M., Maloney P., Gambino R., and Waters R.L. Ethnicity effect on the serum lipid profile in persons with spinal cord injury. Arch Phys Med Rehabil 79 (1998) 176-180
24. Ford E.S., Giles W.H., Myers G.L., and Mannino D.M. Population distribution of high-sensitivity C-reactive protein among US men: findings from National Health and Nutrition Examination Survey 1999-2000. Clin Chem 49 (2003) 686-690
25. Kushner I. C-reactive protein and the acute-phase response. Hosp Pract (Off Ed) 25 (1990) 13 6, 21-8
26. National Center for Health Statistics, Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey data. Hyattsville: U.S. Department of Health and Human Services, CDC; 1999-2000, 2001-2002. http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm Accessed August 15, 2006
27. Shahabi S., Hassan Z.M., Jazani N.H., and Ebtekar M. Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 67 (2006) 900-903
28. Haug S.R., and Heyeraas K.J. Modulation of dental inflammation by the sympathetic nervous system. J Dent Res 85 (2006) 488-495
29. American Spinal Injury Association. International standards for neurological classification of spinal cord injury. 5th ed. (2000), ASIA, Chicago
30. Chumlea W.C., Roche A.F., Mukherjee D., and Steinbaugh M.L. Errors of measurement for methods of recumbent nutritional anthropometry in the elderly. J Nutr Elder 5 (1985) 3-11
31. Williamson D.F., Kahn H.S., Worthman C.M., Burnette J.C., and Russell C.M. Precision of recumbent anthropometry. Am J Hum Biol 15 (1993) 159-167
32. Ford E.S., Giles W.H., and Mokdad A.H. Family history of diabetes or cardiovascular disease and C-reactive protein concentration: findings from the National Health and Nutrition Examination Survey, 1999-2000. Am J Prev Med 29 5 Suppl 1 (2005) 57-62
33. Carroll M.D., Lacher D.A., Sorlie P.D., et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294 (2005) 1773-1781
34. Washburn R.A., Zhu W., McAuley E., Frogley M., and Figoni S.F. The physical activity scale for individuals with physical disabilities: development and evaluation. Arch Phys Med Rehabil 83 (2002) 193-200
35. Ainsworth B.E., Haskell W.L., Leon A.S., et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25 (1993) 71-80
36. Myers G.L., Rifai N., Tracy R.P., et al. CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 110 (2004) e545-e549
37. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001), National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda
38. Plaisance E.P., and Grandjean P.W. Physical activity and high-sensitivity C-reactive protein. Sports Med 36 (2006) 443-458
39. Chrysohoou C., Pitsavos C., Skoumas J., et al. The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study. Int J Cardiol 122 (2007) 29-33
40. Khera A., de Lemos J.A., Peshock R.M., et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 113 (2006) 38-43
41. Chung CP, Oeser A, Solus JF, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis In press.
42. McMahon M., Grossman J., FitzGerald J., et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54 (2006) 2541-2549
43. Budoff M.J., Shinbane J.S., Child J., et al. Multiphase contrast medium injection for optimization of computed tomographic coronary angiography. Acad Radiol 13 (2006) 159-165
44. Orakzai SH, Orakzai RH, Ahmadi N, et al. Measurement of coronary artery calcification by electron beam computerized tomography in persons with chronic spinal cord injury: evidence for increased atherosclerotic burden. Spinal Cord. In press.